Most Canadians unaware of threat of antimicrobial resistance: surveyA new survey looking into Canadians’ knowledge about antimicrobial resistance (AMR) has found that many people are unfamiliar with and unconcerned about the public health risks of AMR. Health Canada approves new tests for diagnosing heart attacks fasterTwo innovative assays that can shorten the time required to diagnose life-threatening heart attacks have been licensed for sale by Health Canada. New facility at Toronto’s MaRS will manufacture cells for clinical trials Equipment protection plan saved hospitals over $2 million last year Health Canada issues advisory about potentially faulty EpiPens Health Canada is warning that some EpiPens may not slide out of their tubes easily, possibly delaying emergency treatment. Amid Canadian shortage, U.S. approves generic EpiPen The U.S. approval comes as Canadian pharmacies deal with a potential shortage of EpiPens this month Growing Canadian medical device firm reaches key financing milestone Ottawa invests in scale initiatives focused on data, health, biosciences Darlington reactors to be new source of critical medical isotope Mo-99 Valeant Pharmaceuticals changing its name following price hike controversies Beginning in July, the Canadian group will be called Bausch Health Companies Inc. First Previous 21 22 23 24 25 Next Last
